Literature DB >> 4052355

Objective evaluation of sensorial and sensorimotorial status in esotropia: their importance in surgical prognosis.

B Bagolini.   

Abstract

Appropriate use of base-out prisms may be useful objective test for detecting persistence of normal binocular vision (4-dioptre prism test). By prolonged observation of prismatic correction of an esotropic patient one may infer the presence of an anomalous sensorial status. This can be done when the prismatic correction is compensated for by an increase of the angle of esotropia (prism adaptation test). The increase in the angle of esotropia induced by base-out prisms, here called anomalous movements, is probably related to a type of anomalous movement fusional in nature. When anomalous movements are present, it is important to realise how powerfully they have developed. This may be inferred by determining what amount of prism overcorrection of the esotropic angle the patient is capable of compensating for (progressive prism compensation test). This has important implications for surgery. It has been statistically demonstrated that esotropia with strong anomalous movements tends to respond less effectively to surgery than esotropia without or with weak anomalous movements.

Entities:  

Mesh:

Year:  1985        PMID: 4052355      PMCID: PMC1040727          DOI: 10.1136/bjo.69.10.725

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  SUBJECTIVE SPACE IN COMITANT SQUINT.

Authors:  B BAGOLINI; N M CAPOBIANCO
Journal:  Am J Ophthalmol       Date:  1965-03       Impact factor: 5.258

2.  Sensorial anomalies in strabismus. (suppression, anomalous correspondence, amblyopia).

Authors:  B Bagolini
Journal:  Doc Ophthalmol       Date:  1976-04-28       Impact factor: 2.379

3.  [Anomalous fusional movements: the sensorimotor aspect of anomalous binocular vision (author's transl)].

Authors:  E C Campos; M R Zanasi
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-01-31

4.  Clinical horopter determination and the mechanism of binocular vision in anomalous correspondence.

Authors:  A W Johnston
Journal:  Ophthalmologica       Date:  1971       Impact factor: 3.250

5.  [Treatment of abnormal retinal correspondence by use of prisms].

Authors:  F E Adelstein; C Cüppers
Journal:  Ann Ocul (Paris)       Date:  1970-05

6.  Atypical responses to the four-diopter prism test.

Authors:  P E Romano; G K Von Noorden
Journal:  Am J Ophthalmol       Date:  1969-06       Impact factor: 5.258

7.  Anomalous correspondence: definition and diagnostic methods.

Authors:  B Bagolini
Journal:  Doc Ophthalmol       Date:  1967       Impact factor: 2.379

Review 8.  A neurophysiological model for anomalous correspondence based on mechanisms of sensory fusion.

Authors:  J I Nelson
Journal:  Doc Ophthalmol       Date:  1981-03-31       Impact factor: 2.379

9.  Postsurgical treatment of convergent strabismus, with a critical evaluation of various tests.

Authors:  B Bagolini
Journal:  Int Ophthalmol Clin       Date:  1966

10.  Sensorio-motorial anomalies in strabismus: (anomalous movements).

Authors: 
Journal:  Doc Ophthalmol       Date:  1976-04-28       Impact factor: 2.379

View more
  4 in total

1.  The irvine prism test: does the positive response indicate suppression scotoma?

Authors:  Sühan Tomaç
Journal:  Int Ophthalmol       Date:  2006-06-19       Impact factor: 2.031

2.  Influence of existing retinal correspondence on the results of squint operations in alternating convergent strabism.

Authors:  M Zehetmayer; E Stangler-Zuschrott; B Schneider
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Surgical correction of convergent strabismus: its relationship to prism compensation.

Authors:  B Bagolini; M R Zanasi; R Bolzani
Journal:  Doc Ophthalmol       Date:  1986-05-15       Impact factor: 2.379

4.  Binocular interactions and steady-state VEPs. A study in normal and defective binocular vision (Part II).

Authors:  B Bagolini; B Falsini; S Cermola; V Porciatti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.